Risk of chemotherapy-induced amenorrhea in patients with breast cancer: a systematic review and meta-analysis

References

• Narod SA. Breast cancer in young women. Nat Rev Clin Oncol 2012;9:460–70.
   PubMed Web of Science ®Google Scholar
• Azim HA, Jr, Michiels S, Bedard PL, Singhal SK, Criscitiello C, Ignatiadis M, et al. Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling. Clin Cancer Res 2012;18:1341–51.
   PubMed Web of Science ®Google Scholar
• Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 2012;379:432–44.
   PubMed Web of Science ®Google Scholar
• Howard-Anderson J, Ganz PA, Bower JE, Stanton AL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst 2012;104:386–405.
   PubMed Web of Science ®Google Scholar
• Ruddy KJ, Gelber SI, Tamimi RM, Ginsburg ES, Schapira L, Come SE, et al. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol 2014;32:1151–6.
   PubMed Web of Science ®Google Scholar
• Partridge AH, Gelber S, Peppercorn J, Ginsburg E, Sampson E, Rosenberg R, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 2004;22:4174–83.
   PubMed Web of Science ®Google Scholar
• Llarena NC, Estevez SL, Tucker SL, Jeruss JS. Impact of fertility concerns on tamoxifen initiation and persistence. J Natl Cancer Inst 2015;107:djv202.
   PubMedGoogle Scholar
• King JW, Davies MC, Roche N, Abraham JM, Jones AL. Fertility preservation in women undergoing treatment for breast cancer in the UK: a questionnaire study. Oncologist 2012;17:910–16.
   PubMed Web of Science ®Google Scholar
• Adams E, Hill E, Watson E. Fertility preservation in cancer survivors: a national survey of oncologists' current knowledge, practice and attitudes. Br J Cancer 2013;108:1602–15.
   PubMed Web of Science ®Google Scholar
• Duffy C, Allen SM, Dube C, Dickersin K. Oncologists' confidence in knowledge of fertility issues for young women with cancer. J Cancer Educ 2012;27:369–76.
   PubMed Web of Science ®Google Scholar
• Torino F, Barnabei A, De Vecchis L, Sini V, Schittulli F, Marchetti P, et al. Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer. Crit Rev Oncol Hematol 2014;89:27–42.
   PubMed Web of Science ®Google Scholar
• Available from: http://www.livestrong.org/we-can-help/fertility-services/risks/. [Accessed March 5, 2016].
   Google Scholar
• Zhao J, Liu J, Chen K, Li S, Wang Y, Yang Y, et al. What lies behind chemotherapy-induced amenorrhea for breast cancer patients: a meta-analysis. Breast Cancer Res Treat 2014;145:113–28.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 2000;283:2008–2012.
   PubMed Web of Science ®Google Scholar
• Viswanathan M, Berkman ND. Development of the RTI item bank on risk of bias and precision of observational studies. J Clin Epidemiol 2012;65:163–78.
   PubMed Web of Science ®Google Scholar
• Valachis A, Nearchou AD, Lind P. Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis. Breast Cancer Res Treat 2014;144:443–55.
   PubMed Web of Science ®Google Scholar
• Davies HT, Crombie IK, Tavakoli M. When can odds ratios mislead? BMJ 1998;316:989–991.
   PubMed Web of Science ®Google Scholar
• Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, et al. American Society of Clinical Oncology. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31:2500–10.
   PubMed Web of Science ®Google Scholar
• Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996;14:1718–29.
   PubMed Web of Science ®Google Scholar
• Speroff L, Glass RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility. 6th ed. Lippincott Williams & Wilkins: Philadelphia, PA, 1999.
   Google Scholar
• Sukumvanich P, Case LD, Van Zee K, Singletary SE, Paskett ED, Petrek JA, et al. Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study. Cancer 2010;116:3102–111.
   PubMed Web of Science ®Google Scholar
• Han HS, Ro J, Lee KS, Nam BH, Seo JA, Lee DH, et al. Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer. Breast Cancer Res Treat 2009;115:335–42.
   PubMed Web of Science ®Google Scholar
• Hargis JB, Nakajima ST. Resumption of menses with initiation of letrozole after five years of amenorrhea on tamoxifen: caution needed when using tamoxifen followed by aromatase inhibitors. Cancer Invest 2006;24:174–7.
   PubMed Web of Science ®Google Scholar
• Smith IE, Dowsett M, Yap YS, Walsh G, Lønning PE, Santen RJ, et al. Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines. J Clin Oncol 2006;24:2444–7.
   PubMed Web of Science ®Google Scholar
• Amir E, Seruga B, Freedman O, Clemons M. Amenorrhoea, menopause, and endocrine therapy for breast cancer BMJ. 2009;339: b4261.
   Google Scholar
• Decanter C, Morschhauser F, Pigny P, Lefebvre C, Gallo C, Dewailly D. Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: Preliminary results. Reprod Biomed Online 2010;20:280–85.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Rosendahl M, Kelsey TW, Cameron DA. Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer. Eur J Cancer 2013; 49:3404–3411.
   PubMed Web of Science ®Google Scholar
• Peigné M, Decanter C. Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic review. Reprod Biol Endocrinol 2014;12:12–26.
   Google Scholar
• Memorial Sloan Kettering Cancer Center. Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations. In: ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US). Available from: https://clinicaltrials.gov/ct2/show/NCT00823654. NLM Identifier: NCT00823654. [Accessed September 27, 2015].
   Google Scholar
• Peking University People's Hospital. Study of Preservation of Ovarian Reserve Function During Chemotherapy for Breast Cancer Patients at Reproductive Age (PORF). In: ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US). Available from: https://clinicaltrials.gov/ct2/show/NCT02430103. NLM Identifier: NCT02430103. [Accessed September 27, 2015].
   Google Scholar
• Riley RD, Lambert PC, Abo-Zaid G: Meta-analysis of individual participant data: rationale, conduct, and reporting BMJ 2010;340:c221.
   PubMed Web of Science ®Google Scholar
• Bonilla L, Ben-Aharon I, Vidal L, Gafter-Gvili A, Leibovici L, Stemmer SM. Dose-dense chemotherapy in nonmetastatic breast cancer: A systematic review and meta-analysis of randomized controlled trials. J Natl Cancer Inst 2010;102:1845–54.
   PubMed Web of Science ®Google Scholar